institutional pathology reviews where available. 6 An undetectable PSA after surgery was not required for study entry, and approximately one third of enrolled patients had a persistently elevated PSA. Patients were randomized within 16 weeks after RP, and those
Search Results
Matthew E. Nielsen, Bruce J. Trock, and Patrick C. Walsh
Rita A. Mukhtar, Jasmine M. Wong, and Laura J. Esserman
imaging and pathology findings, measuring changes in biomarkers such as Ki-67 before and after hormone therapy, and can be adapted to window trials in which new targeted agents are tried in the neoadjuvant setting. 35 In the United Kingdom, the LORIS
Elizabeth A. Nardi, Julie A. Wolfson, Steven T. Rosen, Robert B. Diasio, Stanton L. Gerson, Barbara A. Parker, Joseph C. Alvarnas, Harlan A. Levine, Yuman Fong, Dennis D. Weisenburger, C. Lyn Fitzgerald, Maggie Egan, Sharon Stranford, Robert W. Carlson, and Edward J. Benz Jr
, institutions, and centers. pathology departments at academic cancer centers deliver highly accurate diagnoses of all types of cancer and provide support for complex patient care and stem cell transplantation. They also support broad research platforms
Shi-Yi Wang, Tiange Chen, Weixiong Dang, Sarah S. Mougalian, Suzanne B. Evans, and Cary P. Gross
high-risk groups based on the expected benefit of chemotherapy, as per PREDICT. We abstracted ODX results from medical records, amended pathology reports, genetic-expression profile testing logs, and Genomic Health reports. Among patients who received
Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, Kathleen R. Cho, Christina Chu, David Cohn, Marta Ann Crispens, Don S. Dizon, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Suzanne George, Ernest Han, Susan Higgins, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Fidel A. Valea, Catheryn M. Yashar, Nicole R. McMillian, and Jillian L. Scavone
. Overview The NCCN Uterine Neoplasms Panel is an interdisciplinary group of representatives from NCCN Member Institutions consisting of specialists in gynecologic oncology, medical oncology, radiation oncology, and pathology. The NCCN guidelines for
George Plitas and Charlotte E. Ariyan
the consensus of the American College of Pathology and the International Sentinel Lymph Node Society is to not perform a frozen section. 49 The technique of histologic evaluation of the SLN includes a period of fixation, bisection through the longest
Walburga Yvonne Joko-Fru, Mirko Griesel, Nikolaus Christian Simon Mezger, Lucia Hämmerl, Tobias Paul Seraphin, Jana Feuchtner, Henry Wabinga, Guy N’da, Assefa Mathewos, Bakarou Kamaté, Judith Nsonde Malanda, Freddy Houéhanou Rodrigue Gnangnon, Gladys Chebet Chesumbai, Anne Korir, Cesaltina Lorenzoni, Annelle Zietsman, Margaret Ziona Borok, Biying Liu, Christoph Thomssen, Paul McGale, Ahmedin Jemal, Donald Maxwell Parkin, and Eva Johanna Kantelhardt
. We assumed that many of these patients never actually initiated therapy, and therefore never had a clinical treatment file opened after the pathology report. However, inadequate paper-based record systems and the absence of technological frameworks to
Robert I. Haddad, William M. Lydiatt, Douglas W. Ball, Naifa Lamki Busaidy, David Byrd, Glenda Callender, Paxton Dickson, Quan-Yang Duh, Hormoz Ehya, Megan Haymart, Carl Hoh, Jason P. Hunt, Andrei Iagaru, Fouad Kandeel, Peter Kopp, Dominick M. Lamonica, Judith C. McCaffrey, Jeffrey F. Moley, Lee Parks, Christopher D. Raeburn, John A. Ridge, Matthew D. Ringel, Randall P. Scheri, Jatin P. Shah, Robert C. Smallridge, Cord Sturgeon, Thomas N. Wang, Lori J. Wirth, Karin G. Hoffmann, and Miranda Hughes
2007. 38 , 39 Pathology and cytopathology slides should be reviewed at the treating institution by a pathologist with expertise in the diagnosis of thyroid disorders. Although FNA is a very sensitive test—particularly for papillary thyroid carcinoma
David S. Ettinger, Gregory J. Riely, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D’Amico, Todd L. Demmy, Ramaswamy Govindan, Frederic W. Grannis Jr, Stefan C. Grant, Leora Horn, Thierry M. Jahan, Ritsuko Komaki, Feng-Ming (Spring) Kong, Mark G. Kris, Lee M. Krug, Rudy P. Lackner, Inga T. Lennes, Billy W. Loo Jr, Renato Martins, Gregory A. Otterson, Jyoti D. Patel, Mary C. Pinder-Schenck, Katherine M. Pisters, Karen Reckamp, Eric Rohren, Theresa A. Shapiro, Scott J. Swanson, Kurt Tauer, Douglas E. Wood, Stephen C. Yang, Kristina Gregory, and Miranda Hughes
1981 ; 48 : 2485 – 2492 . 35. Wright CD . Management of thymomas . Crit Rev Oncol Hematol 2008 ; 65 : 109 – 120 . 36. Travis W Brambilla E Muller-Hermelink H Harris C . Pathology and genetics of tumours of the lung, pleura
Carlo C. Maley and Anil K. Rustgi
SJ Goyal R , eds. Barrett's Esophagus: Pathology, Diagnosis and Management . New York : Elsevier ; 1985 : 29 – 37 . 24. Prevo LJ Sanchez CA Galipeau PC . p53-mutant clones and field effects in Barrett's esophagus . Cancer Res 1999
